The previous results indicated that PVRL4 broadly suppressed viral infection by inhibiting viral-cellular membrane fusion, so we evaluated whether PVRL4 can inhibit the infection of SARS-CoV-2, a newly prevalent enveloped RNA virus. Here, NECTIN4 is linked to infection.